blood cancer

September 14, 2016

Restore T cells to fight leukemia

Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients.

By Bill Snyder
March 3, 2016

First VICC cancer patient treated with new immunotherapy

For the first time, Vanderbilt-Ingram Cancer Center (VICC) investigators have used a cancer patient’s own re-engineered immune cells to treat a form of blood cancer by stimulating the immune system.

By VUMC News and Communications
January 21, 2016

Medical staff, theater join forces to help cancer patient see ‘Star Wars’

A Vanderbilt patient who has battled leukemia for nearly five years was granted a private screening of “Star Wars: The Force Awakens,” thanks to her medical providers and a local movie theater.

By VUMC News and Communications
December 11, 2014

Visit unites stem cell transplant patient, donor for first time

When Darlena Clark of Hendersonville, Tennessee, saw Jon Strong for the first time at Nashville International Airport she, “just grabbed him and hugged him and just held on.”

By VUMC News and Communications
June 5, 2014

Pet Therapy Research Aimed at Children with Cancer

By VUMC News and Communications
February 27, 2014

Probing the pathogenesis of leukemia

A new mouse model reveals gene clusters important in a treatment-resistant form of leukemia.

By Leigh MacMillan
September 19, 2013

Hyundai award helps drive hope for cancer research

Emmanuel Volanakis, M.D., assistant professor of Pediatrics and Hematology/Oncology, was awarded a $250,000 Hyundai Hope On Wheels grant last week for his ongoing research into T-cell acute lymphoblastic leukemia (ALL), an aggressive blood cancer.
By Christina Echegaray
June 6, 2013

Leukemia & Lymphoma Society honors Ohi’s research

Puck Ohi, Ph.D., assistant professor of Cell and Developmental Biology, has received the Leukemia & Lymphoma Society SCHOLAR award for his research on the role of enzymes that affect cell division, which has implications for treating cancer and blood disorders like leukemia and lymphoma.
By VUMC News and Communications
April 11, 2013

Leukemia culprit’s cellular actions

Overexpression of a gene that is a common culprit in leukemia induces stem cell-like features in T cells, which may enable the cells to become cancerous.
By Leigh MacMillan